natgillin/translations-raw huggingface dataset:
The markets served by those remaining CCPs could also be severely disrupted in case the transitional period for institutions having exposures to those CCPs is not extended for the same reasons as in case of the non-extension of the transitional periods for CCPs established in the Union.
Tržišta za koja usluge obavljaju te preostale središnje druge ugovorne strane mogla bi se ozbiljno narušiti ako prijelazno razdoblje za institucije koje su izložene prema tim središnjim drugim ugovornim stranama ne bude produženo iz istih razloga kao u slučaju neproduženja prijelaznih razdoblja za središnje druge ugovorne strane s poslovnim nastanom u Uniji.
Commission Implementing Regulation (EU) 2016/893
Provedbena uredba Komisije (EU) 2016/893
Commission Implementing Regulation (EU) 2016/895
Provedbena uredba Komisije (EU) 2016/895
of 8 June 2016
оd 8. lipnja 2016.
amending Regulation (EC) No 1290/2008 as regards the name of the holder of the authorisation of a preparation of Lactobacillus rhamnosus (CNCM-I-3698) and Lactobacillus farciminis (CNCM-I-3699)
o izmjeni Uredbe (EZ) br. 1290/2008 u pogledu naziva nositelja odobrenja pripravka Lactobacillus rhamnosus (CNCM-I-3698) i Lactobacillus farciminis (CNCM-I-3699)
Danisco (UK) Ltd has submitted an application in accordance with Article 13(3) of Regulation (EC) No 1831/2003 proposing to change the name of the holder of the authorisation as regards Commission Regulation (EC) No 1290/2008 [2] concerning the authorisation of a preparation of Lactobacillus rhamnosus (CNCM-I-3698) and Lactobacillus farciminis (CNCM- I-3699).
U skladu s člankom 13. stavkom 3. Uredbe (EZ) br. 1831/2003 društvo Danisco (UK) Ltd. podnijelo je zahtjev za promjenu naziva nositelja odobrenja iz Uredbe Komisije (EZ) br. 1290/2008 [2] o odobrenju pripravka Lactobacillus rhamnosus (CNCM-I-3698) i Lactobacillus farciminis (CNCM-I-3699).
The applicant claims that, with effect from 12 November 2015, Danisco (UK) Ltd has transferred the marketing rights of the preparation of Lactobacillus rhamnosus (CNCM-I-3698) and Lactobacillus farciminis (CNCM- I-3699) to STI Biotechnologie.
Podnositelj zahtjeva tvrdi da je, s učinkom od 12. studenoga 2015., društvo Danisco (UK) Ltd. prenijelo prava stavljanja na tržište pripravka Lactobacillus rhamnosus (CNCM-I-3698) i Lactobacillus farciminis (CNCM-I-3699) na društvo STI Biotechnologie.
The proposed changes of the terms of the authorisation are purely administrative in nature and do not entail a fresh assessment of the additive concerned.
Predložene promjene uvjeta odobrenja posve su administrativne prirode i ne podrazumijevaju novu procjenu predmetnog dodatka.
To allow that feed additive to be marketed under the name of STI Biotechnologie it is necessary to change the terms of the authorisation.
Kako bi se taj dodatak hrani mogao stavljati na tržište pod nazivom STI Biotechnologie, potrebno je izmijeniti uvjete odobrenja.
Regulation (EC) No 1290/2008 should therefore be amended accordingly.
Uredbu (EZ) br. 1290/2008 trebalo bi stoga na odgovarajući način izmijeniti.
Since safety reasons do not require the immediate application of the amendment made by this Regulation to Regulation (EC) No 1290/2008, it is appropriate to provide for a transitional period during which existing stocks of the additive, premixtures and compound feed containing the additive may be used up.
Budući da ne postoje sigurnosni razlozi zbog kojih bi bilo potrebno odmah primjenjivati izmjenu Uredbe (EZ) br. 1290/2008 predviđenu ovom Uredbom, primjereno je osigurati prijelazno razdoblje tijekom kojega se mogu potrošiti postojeće zalihe dodatka te premiksa i krmnih smjesa koji sadržavaju dodatak.
In the Annex to Regulation (EC) No 1290/2008, in the second column, the words ‘Danisco (UK) Ltd’ are replaced by ‘STI Biotechnologie’.
U Prilogu Uredbi (EZ) br. 1290/2008, u drugom stupcu, riječi „Danisco (UK) Ltd” zamjenjuju se riječima „STI Biotechnologie”.
Existing stocks of the additive, premixtures and compound feed containing the additive, which are in conformity with the provisions applying before the date of entry into force of this Regulation may continue to be placed on the market and used until they are exhausted.
Postojeće zalihe dodatka te premiksa i krmnih smjesa koji sadržavaju dodatak, koje su u skladu s odredbama koje se primjenjuju prije datuma stupanja na snagu ove Uredbe, mogu se nastaviti stavljati na tržište i upotrebljavati do njihova isteka.
Done at Brussels, 8 June 2016.
Sastavljeno u Bruxellesu 8. lipnja 2016.
Commission Regulation (EC) No 1290/2008 of 18 December 2008 concerning the authorisation of a preparation of Lactobacillus rhamnosus (CNCM-I-3698) and Lactobacillus farciminis (CNCM-I-3699) as a feed additive (OJ L 340, 19.12.2008, p. 20).
Uredba Komisije (EZ) br. 1290/2008 od 18. prosinca 2008. o odobrenju pripravka Lactobacillus rhamnosus (CNCM-I-3698) i Lactobacillus farciminis (CNCM-I-3699) kao dodatka hrani za životinje (SL L 340, 19.12.2008., str. 20.).
Commission Implementing Regulation (EU) 2016/896
Provedbena uredba Komisije (EU) 2016/896
concerning the authorisation of iron sodium tartrates as a feed additive for all animal species
o odobrenju željeznih natrijevih tartrata kao dodatka hrani za sve životinjske vrste
In accordance with Article 7 of Regulation (EC) No 1831/2003 an application was submitted for the authorisation of iron sodium tartrates.
U skladu s člankom 7. Uredbe (EZ) br. 1831/2003 podnesen je zahtjev za odobrenje željeznih natrijevih tartrata.
That application concerns the authorisation of iron sodium tartrates as a feed additive for all animal species, to be classified in the additive category ‘technological additives’.
Zahtjev se odnosi na odobrenje željeznih natrijevih tartrata kao dodatka hrani za sve životinjske vrste te njihovo razvrstavanje u kategoriju dodataka „tehnološki dodaci”.
The European Food Safety Authority (‘the Authority’) concluded in its opinion of 30 April 2015 [2] that, under the proposed conditions of use, the preparation concerned does not have an adverse effect on animal health, human health or the environment.
Europska agencija za sigurnost hrane („Agencija”) u svojem je mišljenju od 30. travnja 2015. [2] zaključila da navedeni pripravak u predloženim uvjetima uporabe nema negativan učinak na zdravlje životinja, zdravlje ljudi ili na okoliš.
The Authority also concluded that the preparation has the potential to be efficacious as an anti-caking agent in salt.
Agencija je zaključila i da pripravak može biti učinkovit kao tvar za sprečavanje zgrudnjavanja u soli.
It also verified the report on the methods of analysis of the feed additive in feed submitted by the Reference Laboratory set up by Regulation (EC) No 1831/2003.
Isto tako, potvrdila je izvješće o metodama analize dodatka hrani za životinje koje je dostavio referentni laboratorij osnovan Uredbom (EZ) br. 1831/2003.
The assessment of iron sodium tartrates shows that the conditions for authorisation, as provided for in Article 5 of Regulation (EC) No 1831/2003, are satisfied.
Procjena željeznih natrijevih tartrata pokazala je da su ispunjeni uvjeti za odobrenje predviđeni člankom 5. Uredbe (EZ) br. 1831/2003.
Accordingly, the use of that preparation should be authorised as specified in the Annex to this Regulation.
U skladu s tim trebalo bi odobriti uporabu tog pripravka kako je naveden u prilogu ovoj Uredbi.
The preparation specified in the Annex, belonging to the additive category ‘technological additives’ and to the functional group ‘anti-caking agents’ is authorised as an additive in animal nutrition, subject to the conditions laid down in that Annex.
Pripravak naveden u prilogu, koji pripada kategoriji dodataka hrani za životinje „tehnološki dodaci” i funkcionalnoj skupini „tvari za sprečavanje zgrudnjavanja”, odobrava se kao dodatak hrani za životinje pod uvjetima utvrđenima u prilogu.
EFSA Journal 2015; 13(5):4114.
EFSA Journal 2015.; 13(5):4114.
Composition, chemical formula, description, methods of analysis
Sastav, kemijska formula, opis, analitička metoda
mg of active substance/kg of NaCl
mg aktivne tvari/kg NaCl
Iron sodium tartrates
Željezni natrijevi tartrati
Preparation of complexation products of sodium tartrates with iron(III) chloride in water solution ≤ 35 % (by weight).
Pripravak produkata kompleksiranja natrijevih tartrata sa željezo(III) kloridom u vodenoj otopini ≤ 35 % (po težini)
Characterisation of active substance
Karakteristike aktivne tvari:
Iron(III) complexation product of D(+)-, L(-)- and meso-2,3-dihydroxybutanedioic acids
Željezo(III) produkt kompleksiranja D(+)-, L(–)- i mezo-2,3-dihidroksibutanske kiseline
Ratio: iron to meso-tartrate 1:1;
Omjer: željezo i mezo-tartrat 1: 1;
Ratio: iron to total tartrate isomers 1:1,5
Omjer: željezo i ukupni izomeri tartrata 1: 1,5
CAS number 1280193-05-9
CAS broj 1280193-05-9
Chloride: ≤ 25 %
Klorid: ≤ 25 %
Oxalates: ≤ 1,5 % expressed as oxalic acid
Oksalati: ≤ 1,5 %, izraženo kao oksalna kiselina
Iron: ≥ 8 % iron(III)
Željezo: ≥ 8 % željezo(III)
Analytical method [1]Quantification of meso-tartrate and D(-), L(+)-tartrates in the feed additive:
Analitička metoda [1]Kvantifikacija mezo-tartrata i D (–), L (+)-tartrata u dodatku hrani za životinje:
High Performance Liquid Chromatography with Refraction Index detection (HPLC-RI);
tekućinska kromatografija visoke djelotvornosti s detekcijom na osnovi indeksa refrakcije (HPLC-RI),
Quantification of total iron in the feed additive:
Za kvantifikaciju ukupnog željeza u dodatku hrani za životinje:
Inductively Coupled Plasma Atomic Emission Spectroscopy (ICP-AES) — EN 15510, or
atomska emisijska spektrometrija uz induktivno spregnutu plazmu (ICP-AES) – EN 15510, ili
Inductively Coupled Plasma Atomic Emission Spectroscopy after pressure digestion (ICP-AES) — EN 15621,or
atomska emisijska spektrometrija uz induktivno spregnutu plazmu (ICP-AES) nakon razgradnje pod tlakom – EN 15621, ili
Inductively Coupled Plasma Atomic Emission Spectroscopy (ICP-AES) — EN ISO 11885, or
atomska emisijska spektrometrija uz induktivno spregnutu plazmu (ICP-AES) – EN ISO 11885, ili
Atomic Absorption Spectrometry (AAS) — EN ISO 6869, or
atomska apsorpcijska spektrometrija (AAS) – EN ISO 6869, ili
Atomic Absorption Spectrometry (AAS) — Commission Regulation (EC) No 152/2009 [2]; and
atomska apsorpcijska spektrometrija (AAS) – Uredba Komisije (EZ) br. 152/2009 [2], te
Quantification of total sodium in the feed additive:
Za kvantifikaciju ukupnog natrija u dodatku hrani za životinje:
Inductively Coupled Plasma Atomic Emission Spectroscopy (ICP-AES) — EN 15510; or
atomska emisijska spektrometrija uz induktivno spregnutu plazmu (ICP-AES) – EN 15510, ili
Inductively Coupled Plasma Atomic Emission Spectroscopy after pressure digestion (ICP-AES) — EN 15621; or
atomska emisijska spektrometrija uz induktivno spregnutu plazmu (ICP-AES) nakon razgradnje pod tlakom – EN 15621, ili
Inductively Coupled Plasma Atomic Emission Spectroscopy (ICP-AES) — EN ISO 11885; or
atomska emisijska spektrometrija uz induktivno spregnutu plazmu (ICP-AES) – EN 11885, te
Atomic Absorption Spectrometry (AAS) — EN ISO 6869; and
atomska apsorpcijska spektrometrija (AAS) – EN ISO 6869, i
Quantification of total chloride in the feed additive:
Za kvantifikaciju ukupnog klorida u dodatku hrani za životinje:
Titrimetry —Regulation (EC) No 152/2009 or ISO 6495.
titrimetrija – Uredba (EZ) br. 152/2009 ili ISO 6495.
The additive shall be used only in NaCl (sodium chloride).
Dodatak se upotrebljava samo u NaCl (natrijev klorid).
Minimum recommended dose: 26 mg of iron sodium tartrates/kg NaCl (equivalent to 3 mg iron/kg of NaCl).
Najmanja preporučena doza: 26 mg željeznih natrijevih tartrata/kg NaCl (jednako je 3 mg željeza/kg NaCl)
Maximum recommended dose: 106 mg of iron sodium tartrates/kg NaCl.
Najveća preporučena doza: 106 mg željeznih natrijevih tartrata/kg NaCl.
29 June 2026
29. lipnja 2026.
Commission Implementing Regulation (EU) 2016/897
Provedbena uredba Komisije (EU) 2016/897
concerning the authorisation of a preparation of Bacillus subtilis (C-3102) (DSM 15544) as a feed additive for laying hens and ornamental fish (holder of authorisation Asahi Calpis Wellness Co. Ltd) and amending Regulations (EC) No 1444/2006, (EU) No 333/2010 and (EU) No 184/2011 as regards the holder of the authorisation
o odobrenju pripravka Bacillus subtilis (C-3102) (DSM 15544) kao dodatka hrani za životinje za kokoši nesilice i ukrasne ribe (nositelj odobrenja Asahi Calpis Wellness Co. Ltd.) i o izmjeni uredbi (EZ) br. 1444/2006, (EU) br. 333/2010 i (EU) br. 184/2011 u pogledu nositelja odobrenja
Having regard to Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in animal nutrition [1], and in particular Article 9(2) and Article 13(3) thereof,
uzimajući u obzir Uredbu (EZ) br. 1831/2003 Europskog parlamenta i Vijeća od 22. rujna 2003. o dodacima hrani za životinje [1], a posebno njezin članak 9. stavak 2. i članak 13. stavak 3.,
In accordance with Article 7 of Regulation (EC) No 1831/2003 applications were submitted for the authorisation of a preparation of Bacillus subtilis (C-3102).
U skladu s člankom 7. Uredbe (EZ) br. 1831/2003 podneseni su zahtjevi za odobrenje pripravka Bacillus subtilis (C-3102).
Those applications concern the authorisation of a preparation of Bacillus subtilis (C-3102) as a feed additive for all laying birds and ornamental fish to be classified in the additive category ‘zootechnical additives’.
Navedeni se zahtjevi odnose na odobrenje pripravka Bacillus subtilis (C-3102) kao dodatka hrani za sve ptice nesilice i ukrasne ribe i njihovo razvrstavanje u kategoriju dodataka „zootehnički dodaci”.
That preparation was already authorised as a feed additive for use in chickens for fattening by Commission Regulation (EC) No 1444/2006 [2] in piglets by Commission Regulation (EU) No 333/2010 [3], and in chickens reared for laying and turkeys, minor avian species and other ornamental and game birds by Commission Regulation (EU) No 184/2011 [4].
Taj je pripravak već odobren kao dodatak hrani za tovne piliće Uredbom Komisije (EZ) br. 1444/2006 [2], za prasad Uredbom Komisije (EU) br. 333/2010 [3] te za piliće koji se uzgajaju za nesenje, za purane, manje značajne ptičje vrste i druge ukrasne ptice i pernatu divljač Uredbom Komisije (EU) br. 184/2011 [4].
The European Food Safety Authority (‘the Authority’) concluded in its opinions of 28 September 2015 [5] and of 11 November 2015 [6] that, under the proposed conditions of use, the preparation of Bacillus subtilis (C-3102) is presumed not to have an adverse effect on animal health, human health or the environment.
Europska agencija za sigurnost hrane („Agencija”) u svojim je mišljenjima od 28. rujna 2015. [5] i 11. studenoga 2015.
It concluded that, under the proposed condition of use, the additive has the potential to be efficacious in reducing the amount of feed per unit of mass egg production over the entire laying period.
zaključila da se smatra da u predloženim uvjetima uporabe pripravak Bacillus subtilis (C-3102) nema negativan učinak na zdravlje životinja, zdravlje ljudi ili na okoliš. Agencija je zaključila da u predloženim uvjetima uporabe pripravak može biti učinkovit za smanjenje količine hrane po jedinici mase proizvodnje jaja tijekom cijelog razdoblja nesenja.
The Authority also concluded that the additive has the potential to improve the grow and feed utilisation in ornamental fish.
Agencija je isto tako zaključila da taj dodatak može poboljšati rast ukrasnih riba i utrošak hrane za njih.
The assessment of the preparation of Bacillus subtilis (C-3102) shows that the conditions for authorisation, as provided for in Article 5 of Regulation (EC) No 1831/2003, are satisfied.
Procjena pripravka Bacillus subtilis (C-3102) pokazala je da su ispunjeni uvjeti za odobrenje predviđeni člankom 5. Uredbe (EZ) br. 1831/2003.
The applicant has also submitted an application in accordance with Article 13(3) of Regulation (EC) No 1831/2003 proposing to change the name of the holder of the authorisation and the name of its representative in the EU in Regulations (EC) No 1444/2006, (EU) No 333/2010 and (EU) No 184/2011.
Podnositelj zahtjeva podnio je i zahtjev u skladu s člankom 13. stavkom 3. Uredbe (EZ) br. 1831/2003 za promjenu naziva nositelja odobrenja i naziva njegova predstavnika u EU-u iz uredbi (EZ) br. 1444/2006, (EU) br. 333/2010 i (EU) br. 184/2011.
The applicant has submitted relevant data supporting its request.
Podnositelj zahtjeva dostavio je relevantne podatke kojima podupire svoj zahtjev.
In order to enable Asahi Calpis Wellness Co. Ltd to exploit its marketing rights it is necessary to change the terms of the authorisations.
Kako bi se društvu Asahi Calpis Wellness Co. Ltd. omogućilo korištenje prava stavljanja na tržište, potrebno je izmijeniti uvjete odobrenja.
Regulations (EC) No 1444/2006, (EU) No 333/2010 and (EU) No 184/2011 should therefore be amended accordingly.
Uredbe (EZ) br. 1444/2006, (EU) br. 333/2010 i (EU) br. 184/2011 trebalo bi stoga na odgovarajući način izmijeniti.
In the Annex to Regulation (EC) No 1444/2006, in the second column, name of the holder of authorisation, the term ‘Calpis Co., Ltd represented in the Community by Orffa International Holding BV’ is replaced by the term ‘Asahi Calpis Wellness Co. Ltd, represented in the European Union by Asahi Calpis Wellness Co. Ltd Europe Representative Office’.
U Prilogu Uredbi Komisije (EZ) br. 1444/2006, u drugom stupcu, naziv nositelja odobrenja, izraz „Calpis Co., Ltd., kojeg u Zajednici zastupa Orffa International Holding BV” zamjenjuje se izrazom „Asahi Calpis Wellness Co. Ltd., kojeg u Europskoj uniji zastupa Asahi Calpis Wellness Co. Ltd. Europe Representative Office”.
Regulation (EU) No 333/2010 is amended as follows:
Uredba (EU) br. 333/2010 mijenja se kako slijedi:
in the title, the term ‘holder of authorisation Calpis Co. Ltd Japan, represented in the European Union by Calpis Co. Ltd Europe Representative Office’ is replaced by the term ‘holder of authorisation Asahi Calpis Wellness Co. Ltd, represented in the European Union by Asahi Calpis Wellness Co. Ltd Europe Representative Office’;
u naslovu, izraz „nositelj odobrenja Calpis Co. Ltd. Japan, kojeg u Europskoj uniji zastupa Calpis Co. Ltd. Europe Representative Office” zamjenjuje se izrazom „nositelj odobrenja Asahi Calpis Wellness Co. Ltd., kojeg u Europskoj uniji zastupa Asahi Calpis Wellness Co. Ltd. Europe Representative Office”;
in the Annex, in the second column, name of the holder of authorisation, the term ‘Calpis Co. Ltd Japan, represented in the European Union by Calpis Co. Ltd Europe Representative Office, France’ is replaced by the term ‘Asahi Calpis Wellness Co. Ltd, represented in the European Union by Asahi Calpis Wellness Co. Ltd Europe Representative Office’.
u Prilogu, u drugom stupcu, naziv nositelja odobrenja, izraz „Calpis Co. Ltd. Japan, kojeg u Europskoj uniji zastupa Calpis Co. Ltd. Europe Representative Office, Francuska” zamjenjuje se izrazom „Asahi Calpis Wellness Co. Ltd., kojeg u Europskoj uniji zastupa Asahi Calpis Wellness Co. Ltd. Europe Representative Office”.
Regulation (EU) No 184/2011 is amended as follows:
Uredba (EU) br. 184/2011 mijenja se kako slijedi:
in the title, the term ‘holder of authorisation Calpis Co. Ltd Japan, represented by Calpis Co. Ltd Europe Representative Office’ is replaced by the term ‘holder of authorisation Asahi Calpis Wellness Co. Ltd, represented in the European Union by Asahi Calpis Wellness Co. Ltd Europe Representative Office’;
u naslovu, izraz „nositelj odobrenja Calpis Co. Ltd. Japan, kojeg zastupa Calpis Co. Ltd. Europe Representative Office” zamjenjuje se izrazom „nositelj odobrenja Asahi Calpis Wellness Co. Ltd., kojeg u Europskoj uniji zastupa Asahi Calpis Wellness Co. Ltd. Europe Representative Office”;
in the Annex, in the second column, name of the holder of authorisation, the term ‘Calpis Co. Ltd Japan, represented by Calpis Co. Ltd Europe Representative Office, France’ is replaced by the term ‘Asahi Calpis Wellness Co. Ltd, represented in the European Union by Asahi Calpis Wellness Co. Ltd Europe Representative Office’.
u Prilogu, u drugom stupcu, naziv nositelja odobrenja, izraz „Calpis Co. Ltd. Japan, kojeg zastupa Calpis Co. Ltd. Europe Representative Office, Francuska” zamjenjuje se izrazom „Asahi Calpis Wellness Co. Ltd., kojeg u Europskoj uniji zastupa Asahi Calpis Wellness Co. Ltd. Europe Representative Office”.
Commission Regulation (EC) No 1444/2006 of 29 September 2006 concerning the authorisation of Bacillus subtilis C-3102 (Calsporin) as a feed additive (OJ L 271, 30.9.2006, p. 19).
Uredba Komisije (EZ) br. 1444/2006 od 29. rujna 2006. o izdavanju odobrenja za Bacillus subtilis C-3102 (Calsporin) kao dodatka hrani za životinje (SL L 271, 30.9.2006., str. 19.).
Commission Regulation (EU) No 333/2010 of 22 April 2010 concerning the authorisation of a new use of Bacillus subtilis C-3102 (DSM 15544) as a feed additive for weaned piglets (holder of authorisation Calpis Co. Ltd Japan, represented in the European Union by Calpis Co. Ltd Europe Representative Office) (OJ L 102, 23.4.2010, p. 19).
Uredba Komisije (EU) br. 333/2010 od 22. travnja 2010. o odobrenju novog korištenja Bacillus subtilis C-3102 (DSM 15544) kao dodatka hrani za odbijenu prasad (nositelj odobrenja Calpis Co. Ltd. Japan, kojeg u Europskoj uniji zastupa Calpis Co. Ltd. Europe Representative Office) (SL L 102, 23.4.2010., str. 19.).
Commission Regulation (EU) No 184/2011 of 25 February 2011 concerning the authorisation of Bacillus subtilis C-3102 (DSM 15544) as a feed additive for chickens reared for laying, turkeys, minor avian species and other ornamental and game birds (holder of authorisation Calpis Co. Ltd Japan, represented by Calpis Co. Ltd Europe Representative Office) (OJ L 53, 26.2.2011, p. 33).
Uredba Komisije (EU) br. 184/2011 od 25. veljače 2011. o odobrenju Bacillus subtilis C-3102 (DSM 15544) kao dodatka hrani za životinje za piliće koji se uzgajaju za nesenje, za purane, manje značajne ptičje vrste i druge ukrasne ptice i pernatu divljač (nositelj odobrenja Calpis Co. Ltd Japan, kojega zastupa Calpis Co. Ltd Europe Representative Office) (SL L 53, 26.2.2011., str. 33.).
EFSA Journal 2015; 13(9):4231.
EFSA Journal (2015.); 13(9):4231.
EFSA Journal 2015; 13(11):4274.
EFSA Journal (2015.); 13(11):4274.
Asahi Calpis Wellness Co. Ltd, represented in the European Union by Asahi Calpis Wellness Co. Ltd Europe Representative Office
Asahi Calpis Wellness Co. Ltd., kojeg u Europskoj uniji zastupa Asahi Calpis Wellness Co. Ltd. Europe Representative Office
Bacillus subtilis C-3102 (DSM 15544) with minimum of 1,0 × 1010 CFU/g
Bacillus subtilis C-3102 (DSM 15544) s najmanje 1,0 × 1010 CFU/g
Viable spores (CFU) of Bacillus subtilis C-3102 (DSM 15544)
Žive spore (CFU) Bacillus subtilis C-3102 (DSM 15544)
Analytical method [1]Enumeration: spread plate method using tryptone soya agar in all target matrices (EN 15784:2009)
Analitička metoda [1]Određivanje brojnosti: metoda razmazivanja uz uporabu triptonskog soja agara u svim ciljnim matricama (EN 15784:2009)
Identification: pulsed-field gel electrophoresis (PFGE).
Identifikacija: gel-elektroforeza u pulsirajućem polju (PFGE).
In the directions for use of the additive, premixture and compound feedingstuff indicate the storage temperature, storage life and stability to pelleting shall be indicated.
U uputama za uporabu dodatka hrani, premiksa i krmne smjese potrebno je navesti temperaturu skladištenja, rok valjanosti i stabilnost pri peletiranju.
For users of the additive and premixtures in a feed business, operational procedures and appropriate organisational measures shall be established to address hazards by inhalation, dermal contact or eyes contact.
Zbog opasnosti od udisanja, doticaja s kožom ili očima, za korisnike dodatka i premiksa koji posluju s hranom potrebno je utvrditi radne postupke i odgovarajuće operativne postupke.
Where the dermal, inhalator or eyes exposure cannot be reduced to an acceptable level by these procedures and measures, the additive and premixtures shall be used with appropriate personal protective equipment.
Ako se izloženost putem kože, očiju ili udisanja s pomoću tih postupaka i mjera ne može smanjiti na prihvatljivu razinu, pri uporabi dodataka i premiksa potrebno je nositi odgovarajuću osobnu zaštitnu opremu.